Literature DB >> 2144412

Myosin heavy and light chain expression during human skeletal muscle development and precocious muscle maturation induced by thyroid hormone.

G S Butler-Browne1, J P Barbet, L E Thornell.   

Abstract

It has now been well established that during mammalian muscle development there is a sequential transition of the myosin isoforms, with the developmental isoforms being replaced just before or just after birth by the adult isozymes. In a previous study of human fetal muscle, we demonstrated the differentiation of two fiber populations as early as 15 weeks: one population of large diameter fibers containing predominantly slow myosin heavy and light chains, and another population which stained homogeneously for fetal myosin heavy chain and corresponded to histochemical type IIC fibers. We have carried out an immunocytochemical and biochemical study of human fetal quadriceps between 7 and 40 weeks. A chronology of the changes which occur in the expression of the myosin heavy and light chains is correlated with the results obtained by enzyme histochemistry. Evidence is also presented that in man excessive amounts of thyroid hormone act directly on the muscle, and result in a precocious accumulation of the adult myosin heavy chains and a precocious maturation of the muscle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144412     DOI: 10.1007/bf00174624

Source DB:  PubMed          Journal:  Anat Embryol (Berl)        ISSN: 0340-2061


  46 in total

1.  [Histochemical, quantitative and ultrastructural maturation of human fetal muscle].

Authors:  E Farkas-Bargeton; M F Diebler; M L Arsénio-Nunes; R Wehrlé; B Rosenberg
Journal:  J Neurol Sci       Date:  1977-03       Impact factor: 3.181

2.  Three "myosin adenosine triphosphatase" systems: the nature of their pH lability and sulfhydryl dependence.

Authors:  M H Brooke; K K Kaiser
Journal:  J Histochem Cytochem       Date:  1970-09       Impact factor: 2.479

3.  Expression of myosin light chains during fetal development of human skeletal muscle.

Authors:  F Pons; A Damadei; J J Leger
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

4.  An electrophoretic study of native myosin isozymes and of their subunit content.

Authors:  A d'Albis; C Pantaloni; J J Bechet
Journal:  Eur J Biochem       Date:  1979-09

5.  Development of fiber types in human fetal muscle. An immunocytochemical study.

Authors:  L E Thornell; R Billeter; G S Butler-Browne; P O Eriksson; M Ringqvist; R G Whalen
Journal:  J Neurol Sci       Date:  1984-10       Impact factor: 3.181

6.  Myosin types in human skeletal muscle fibers.

Authors:  R Billeter; H Weber; H Lutz; H Howald; H M Eppenberger; E Jenny
Journal:  Histochemistry       Date:  1980

7.  Influence of the dwarf mouse mutation on skeletal and cardiac myosin isoforms. Effect of one injection of thyroxine on skeletal and cardiac muscle phenotype.

Authors:  G S Butler-Browne; G Prulière; N Cambon; R G Whalen
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

8.  Regulation of myosin isoenzyme composition in fetal and neonatal rat ventricle by endogenous thyroid hormones.

Authors:  R A Chizzonite; R Zak
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

9.  Adult human masseter muscle fibers express myosin isozymes characteristic of development.

Authors:  G S Butler-Browne; P O Eriksson; C Laurent; L E Thornell
Journal:  Muscle Nerve       Date:  1988-06       Impact factor: 3.217

10.  Myosin subunit composition in human developing muscle.

Authors:  D Biral; E Damiani; A Margreth; E Scarpini
Journal:  Biochem J       Date:  1984-12-15       Impact factor: 3.857

View more
  21 in total

1.  Characterisation of human soft palate muscles with respect to fibre types, myosins and capillary supply.

Authors:  P S Stål; R Lindman
Journal:  J Anat       Date:  2000-08       Impact factor: 2.610

2.  Extrasynaptic location of laminin beta 2 chain in developing and adult human skeletal muscle.

Authors:  U M Wewer; L E Thornell; F Loechel; X Zhang; M E Durkin; S Amano; R E Burgeson; E Engvall; R Albrechtsen; I Virtanen
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 3.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

4.  Opposite changes in myosin heavy chain composition of human masseter and biceps brachii muscles during aging.

Authors:  M Monemi; P O Eriksson; F Kadi; G S Butler-Browne; L E Thornell
Journal:  J Muscle Res Cell Motil       Date:  1999-05       Impact factor: 2.698

5.  Familial fetal akinesia deformation sequence with a skeletal muscle maturation defect.

Authors:  K Vuopala; F Pedrosa-Domellöf; R Herva; J Leisti; L E Thornell
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 6.  Thyroid Hormone Signalling: From the Dawn of Life to the Bedside.

Authors:  Iordanis Mourouzis; Angelo Michele Lavecchia; Christodoulos Xinaris
Journal:  J Mol Evol       Date:  2019-08-27       Impact factor: 2.395

7.  Thyroid Hormone Signaling in Muscle Development, Repair and Metabolism.

Authors:  Jang-Won Lee; Nam-Ho Kim; Anna Milanesi
Journal:  J Endocrinol Diabetes Obes       Date:  2014 Jul-Sep

8.  Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers.

Authors:  Alastair Khodabukus; Amulya Kaza; Jason Wang; Neel Prabhu; Richard Goldstein; Vishal S Vaidya; Nenad Bursac
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

9.  Effects of elevated thyroid hormone on adult rabbit extraocular muscles.

Authors:  Andrew R Harrison; Michael S Lee; Linda K McLoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

Review 10.  Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Miranda D Grounds; Hannah G Radley; Gordon S Lynch; Kanneboyina Nagaraju; Annamaria De Luca
Journal:  Neurobiol Dis       Date:  2008-04-09       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.